Specialized CNS consulting

CNS therapeutics, CSF drug delivery, and hydrocephalus consulting

Flux Neuroscience provides strategic and technical support for biotech, medtech, academic, and investor teams working in central nervous system therapeutics, medical devices, cerebrospinal fluid biology, translational research, and preclinical development.

Deep technical expertise for specialized CNS programs

Flux Neuroscience, LLC is a consultancy led by Bryn Martin, Ph.D., P.E. For two decades, Dr. Martin has studied cerebrospinal fluid diseases, diagnostics, and therapeutics, with particular expertise in targeted CSF drug delivery, neuroengineering, imaging, and translational development.

20+ Years of CSF-focused research and development experience
65+ Peer-reviewed publications across CSF and neuroengineering topics
PI Principal Investigator experience across federal, foundation, and industry-supported work
CNS Expertise spanning therapeutics, devices, imaging, modeling, and translational studies

Services

How Flux Neuroscience can help

  • Intrathecal / CSF drug delivery and pharmacokinetic strategy for CNS therapeutics, gene and cell therapy, pain, oncology, and related programs
  • Hydrocephalus, intracranial pressure, shunt, and related device or clinical technology advisory
  • Biomedical imaging, neuroimaging, MRI, PET, IHC, instrumentation, and quantitative measurement strategy
  • In vitro and bench-top model design and development for biomedical applications
  • Preclinical large-animal R&D and translational planning for drugs, biologics, and medical devices
  • Clinical research support including protocol concepts, CRF development, informed consent considerations, and human imaging workflows

Additional strategic support

  • Scientific, technical, and IP diligence for emerging technologies
  • Non-dilutive funding strategy, grant writing support, and federal funding system setup
  • Biomechanics, biofluid mechanics, neurophysiology, and neuroengineering problem solving
  • Translation of complex scientific programs into clear development plans, investor materials, or technical decision frameworks

Who we work with

  • Biotech and medtech startups building CNS therapeutics, diagnostics, or devices
  • Academic and translational teams advancing promising research toward development
  • Established companies needing specialized CSF, hydrocephalus, or imaging expertise
  • Investors and partners performing scientific, technical, or IP diligence

Why clients engage Flux Neuroscience

  • Rare depth in CSF physiology, drug delivery, hydrocephalus, imaging, and biofluid mechanics
  • Ability to bridge technical details with strategic development decisions
  • Experience across therapeutics, devices, translational studies, grants, and diligence
  • Flexible support for one-time projects, diligence engagements, and ongoing advisory work

Representative project support

Example engagements may include targeted technical diligence, program design, translational planning, and specialized scientific advisory support for complex CNS programs.

Therapeutic strategy

Advising on intrathecal delivery approach, CSF pharmacokinetics, and translational considerations for CNS therapeutic programs.

Device development

Supporting hydrocephalus, shunt, ICP, and related device concepts with engineering, preclinical, and clinical perspective.

Diligence and grants

Providing scientific and IP diligence, technical review, and non-dilutive funding strategy for emerging technologies.

Start a conversation

Flux Neuroscience works with clients who need highly specialized scientific and technical guidance in CNS therapeutics, drug delivery, hydrocephalus, and neuroengineering.

Reach out to discuss a consulting project, advisory role, technical diligence engagement, or collaboration opportunity.

Bryn A. Martin, Ph.D., P.E.

Manager, Flux Neuroscience, LLC

mail@fluxneuroscience.com

+1-330-475-9747

www.fluxneuroscience.com